A phase 1, open-label safety and immunogenicity study of an AS03-adjuvanted trivalent inactivated influenza vaccine in children aged 6 to 35 months

Por Carmona Martinez, Alfonso, Salamanca de la Cueva, Ignacio, Boutet, Philippe, Vanden Abeele, Carline, Smolenov, Igor, Devaster, Jeanne-Marie
Publicado em 2014

Immunogenicity and Safety of an Inactivated Quadrivalent Influenza Vaccine Candidate: A Phase III Randomized Controlled Trial in Children

Por Langley, Joanne M., Carmona Martinez, Alfonso, Chatterjee, Archana, Halperin, Scott A., McNeil, Shelly, Reisinger, Keith S., Aggarwal, Naresh, Huang, Li-Min, Peng, Ching-Tien, Garcia-Sicilia, José, Salamanca de la Cueva, Ignacio, Cabañas, Fernando, Treviño-Garza, Consuelo, Rodríguez-Weber, Miguel Angel, de la O, Manuel, Chandrasekaran, Vijayalakshmi, Dewé, Walthère, Liu, Aixue, Innis, Bruce L., Jain, Varsha K.
Publicado em 2013